Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation

• Nasser Abualhassan ,

  Contributed equally to this work with: Nasser Abualhassan, Lena Sapozhnikov

  Affiliation Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada

  ⨯
• Lena Sapozhnikov ,

  Contributed equally to this work with: Nasser Abualhassan, Lena Sapozhnikov

  Affiliation Department of Cell and Developmental Biology, The Hebrew University of Jerusalem, Jerusalem, Israel

  ⨯
• Rena L. Pawlick,

  Affiliation Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada

  ⨯
• Meygal Kahana,

  Affiliation Department of Cell and Developmental Biology, The Hebrew University of Jerusalem, Jerusalem, Israel

  ⨯
• Andrew R. Pepper,

  Affiliation Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada

  ⨯
• Antonio Bruni,

  Affiliation Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada

  ⨯
• Boris Gala-Lopez,

  Affiliation Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada

  ⨯
• Tatsuya Kin,

  Affiliation Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada

  ⨯
• Eduardo Mitrani ,

  * E-mail: mitrani@vms.huji.ac.il

  ¶‡ These authors are joint senior authors on this work.

  Affiliation Department of Cell and Developmental Biology, The Hebrew University of Jerusalem, Jerusalem, Israel

  ⨯
• A. M. James Shapiro

  ¶‡ These authors are joint senior authors on this work.

  Affiliations Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada, Clinical Islet Transplant Program, University of Alberta, Edmonton, AB, Canada

  ⨯